Sutton Wealth Advisors Inc. Uni Qure N.V. Transaction History

Sutton Wealth Advisors Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Nov 07, 2023	SELL	$18.7 - $23.07 $10,341 - $12,757	-553 Closed	0 $0
Q4 2022 Nov 07, 2023	BUY	$18.12 - $27.32 $9,929 - $14,971	548 Added 10960.0%	553 $12.5 Million
Q3 2022 Nov 07, 2023	SELL	$16.98 - $25.54 $8,642 - $12,999	-509 Reduced 99.03%	5 $94,000
Q1 2022 Nov 07, 2023	BUY	$14.54 - $21.5 $1,279 - $1,892	88 Added 20.66%	514 $9.29 Million
Q4 2021 Nov 07, 2023	SELL	$20.24 - $36.01 $1,801 - $3,204	-89 Reduced 17.28%	426 $8.84 Million
Q3 2021 Nov 07, 2023	BUY	$26.01 - $38.22 $13,395 - $19,683	515 New	515 $16.5 Million

199

53.7M

4.43M

1.27M

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $1.3B
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.